price
PH
NASDAQ · PHAR
Pharming Group N.V.
Healthcare · Biotechnology
$10.55
Down-$0.23 (-2.13%)
Updated Sep 19, 2026, 1:31 PM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.2B
- P/E ratio
- 3,147.1
- Dividend yield
- 0.00%
- 52-week range
- $9.62 – $18.41
- Volume
- 7.85K
- Avg. volume
- 16.7K
Price performance
PHAR price history
1M range · 20 trading sessions · Daily adjusted prices
PHAR closed at $10.55 after 20 trading sessions, down 10.97% for the selected period.
- Last close
- $10.55
- Period change
- -10.97%
- Period low
- $10.55
- Period high
- $11.95
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $10.72 | $10.75 | $10.50 | $10.55 | 7.85K |
| Sep 17, 2026 | $10.73 | $10.945 | $10.73 | $10.78 | 5.4K |
| Sep 16, 2026 | $10.67 | $10.75 | $10.50 | $10.60 | 58.03K |
| Sep 15, 2026 | $10.82 | $10.83 | $10.4397 | $10.55 | 15.27K |
| Sep 14, 2026 | $10.78 | $11.1926 | $10.72 | $10.82 | 19.68K |
| Sep 11, 2026 | $10.82 | $11.693 | $10.6516 | $11.21 | 39.07K |
| Sep 10, 2026 | $10.91 | $10.9695 | $10.67 | $10.805 | 15.34K |
| Sep 9, 2026 | $11.15 | $11.54 | $10.97 | $10.97 | 12.13K |
| Sep 8, 2026 | $11.38 | $11.50 | $11.30 | $11.50 | 21.51K |
| Sep 4, 2026 | $11.16 | $11.54 | $11.16 | $11.23 | 5.54K |
| Sep 3, 2026 | $11.38 | $11.48 | $11.305 | $11.46 | 5.35K |
| Sep 2, 2026 | $11.5118 | $11.5506 | $11.20 | $11.20 | 4.99K |
| Sep 1, 2026 | $11.36 | $11.59 | $11.0292 | $11.11 | 34.51K |
| Aug 31, 2026 | $11.50 | $11.66 | $11.48 | $11.48 | 12.36K |
| Aug 28, 2026 | $11.81 | $11.81 | $11.6284 | $11.70 | 9.45K |
| Aug 27, 2026 | $11.835 | $11.96 | $11.7701 | $11.78 | 6.43K |
| Aug 26, 2026 | $11.86 | $12.32 | $11.72 | $11.95 | 35.54K |
| Aug 25, 2026 | $11.67 | $11.96 | $11.67 | $11.77 | 21.51K |
| Aug 24, 2026 | $11.62 | $12.21 | $11.4501 | $11.46 | 23.17K |
| Aug 21, 2026 | $11.76 | $11.97 | $11.73 | $11.85 | 11.01K |
Latest PHAR news
The latest Smart Investors Daily articles mentioning PHAR.
Stock researchResearch & News · SEC Filings
Loading stock research…

